Generic and specific recurrent neural network models: Applications for large and small scale biopharmaceutical upstream processes.

37N25 46N60 62M10 92B20 Autocorrelation functions Generic and specific machine learning models Principal component analysis Recurrent neural networks Simulation of bioreactor processes Temporal evolution Upstream processes

Journal

Biotechnology reports (Amsterdam, Netherlands)
ISSN: 2215-017X
Titre abrégé: Biotechnol Rep (Amst)
Pays: Netherlands
ID NLM: 101637426

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 04 02 2021
revised: 24 04 2021
accepted: 27 05 2021
entrez: 23 6 2021
pubmed: 24 6 2021
medline: 24 6 2021
Statut: epublish

Résumé

The calculation of temporally varying upstream process outcomes is a challenging task. Over the last years, several parametric, semi-parametric as well as non-parametric approaches were developed to provide reliable estimates for key process parameters. We present generic and product-specific recurrent neural network (RNN) models for the computation and study of growth and metabolite-related upstream process parameters as well as their temporal evolution. Our approach can be used for the control and study of single product-specific large-scale manufacturing runs as well as generic small-scale evaluations for combined processes and products at development stage. The computational results for the product titer as well as various major upstream outcomes in addition to relevant process parameters show a high degree of accuracy when compared to experimental data and, accordingly, a reasonable predictive capability of the RNN models. The calculated values for the root-mean squared errors of prediction are significantly smaller than the experimental standard deviation for the considered process run ensembles, which highlights the broad applicability of our approach. As a specific benefit for platform processes, the generic RNN model is also used to simulate process outcomes for different temperatures in good agreement with experimental results. The high level of accuracy and the straightforward usage of the approach without sophisticated parameterization and recalibration procedures highlight the benefits of the RNN models, which can be regarded as promising alternatives to existing parametric and semi-parametric methods.

Identifiants

pubmed: 34159058
doi: 10.1016/j.btre.2021.e00640
pii: S2215-017X(21)00056-4
pmc: PMC8193373
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e00640

Informations de copyright

© 2021 The Authors.

Références

Nat Rev Mol Cell Biol. 2020 Dec;21(12):729-749
pubmed: 33087899
Biotechnol Bioeng. 2021 May;118(5):1793-1804
pubmed: 33491766
Biotechnol Prog. 2020 Jul;36(4):e2984
pubmed: 32087049
Phys Chem Chem Phys. 2020 Nov 14;22(42):24359-24364
pubmed: 33084665
Drug Discov Today. 2015 Mar;20(3):318-31
pubmed: 25448759
Bioprocess Biosyst Eng. 2020 Feb;43(2):169-178
pubmed: 31541314
Biotechnol Prog. 2018 Nov;34(6):1407-1426
pubmed: 30290072
Trends Biotechnol. 2008 Apr;26(4):166-72
pubmed: 18261813
Curr Opin Biotechnol. 2013 Dec;24(6):973-8
pubmed: 23611566
Biotechnol J. 2018 Mar;13(3):e1700499
pubmed: 29393587
Bioprocess Biosyst Eng. 2019 May;42(5):867-882
pubmed: 30806781
J Phys Chem B. 2014 Oct 9;118(40):11613-21
pubmed: 25207443
Biotechnol Bioeng. 2019 Oct;116(10):2540-2549
pubmed: 31237678
Bioprocess Biosyst Eng. 2016 May;39(5):773-84
pubmed: 26879643
Biotechnol Prog. 2021 Jan;37(1):e3081
pubmed: 32926575
Acc Chem Res. 2018 May 15;51(5):1281-1289
pubmed: 29715002
Biotechnol J. 2020 May;15(5):e1900551
pubmed: 32022416
J Chem Phys. 2014 Apr 28;140(16):164904
pubmed: 24784307
Biotechnol Prog. 2020 Sep;36(5):e3012
pubmed: 32364635
Bioprocess Biosyst Eng. 2020 Aug;43(8):1381-1389
pubmed: 32211960
Biotechnol J. 2018 Apr;13(4):e1700395
pubmed: 29149549
J Chromatogr A. 2016 Sep 23;1465:71-8
pubmed: 27575919
J Chromatogr A. 2016 May 13;1446:10
pubmed: 27079748
Bioengineering (Basel). 2017 Mar 08;4(1):
pubmed: 28952500
Trends Biotechnol. 2020 Oct;38(10):1141-1153
pubmed: 32518043
Neural Netw. 2006 Mar;19(2):135-44
pubmed: 16527456
Neural Comput. 1997 Nov 15;9(8):1735-80
pubmed: 9377276
Bioprocess Biosyst Eng. 2020 Aug;43(8):1431-1443
pubmed: 32266469
Int J Pharm X. 2019 Mar 17;1:100010
pubmed: 31517275
Neural Netw. 1998 Jun;11(4):761-767
pubmed: 12662814
Biotechnol Bioeng. 2020 Dec;117(12):3986-4000
pubmed: 32725887
Biotechnol J. 2012 Jan;7(1):61-74
pubmed: 22102428
J Phys Chem B. 2014 Jan 23;118(3):771-82
pubmed: 24354598
Biotechnol Prog. 2018 Sep;34(5):1120-1128
pubmed: 30281943
Nature. 2018 Mar 28;555(7698):604-610
pubmed: 29595767
Biotechnol Prog. 2002 Sep-Oct;18(5):1095-103
pubmed: 12363363
Biotechnol J. 2020 Sep;15(9):e2000121
pubmed: 32501577
Nat Commun. 2017 Jan 09;8:13890
pubmed: 28067221
Biotechnol Bioeng. 2019 Nov;116(11):2919-2930
pubmed: 31317536
Adv Biochem Eng Biotechnol. 2012;127:133-63
pubmed: 21290218
Appl Microbiol Biotechnol. 2017 Nov;101(22):8101-8113
pubmed: 28951949
J Chem Phys. 2009 Jun 28;130(24):244702
pubmed: 19566169
Metab Eng. 2010 Mar;12(2):161-71
pubmed: 19833223
Adv Biochem Eng Biotechnol. 2021;176:133-180
pubmed: 33205260
Eng Life Sci. 2017 Dec 19;18(3):204-214
pubmed: 32624899
Bioprocess Biosyst Eng. 2019 Nov;42(11):1853-1865
pubmed: 31375965
Int J Neural Syst. 2004 Apr;14(2):69-106
pubmed: 15112367
J Chromatogr A. 2018 Jan 19;1533:66-76
pubmed: 29229331
Drug Discov Today. 2018 Jun;23(6):1241-1250
pubmed: 29366762
J Chromatogr A. 2019 Feb 22;1587:101-110
pubmed: 30579636
J Ind Microbiol Biotechnol. 2015 Mar;42(3):317-25
pubmed: 25613286
Biotechnol J. 2014 Jun;9(6):719-26
pubmed: 24806479
Biotechnol J. 2020 Jan;15(1):e1900172
pubmed: 31486583
J Phys Chem Lett. 2015 Jun 18;6(12):2326-31
pubmed: 26113956

Auteurs

Jens Smiatek (J)

Institute for Computational Physics, University of Stuttgart, D-70569 Stuttgart, Germany.
Boehringer Ingelheim Pharma GmbH & Co. KG, Digitalization Development Biologicals CMC, D-88397 Biberach (Riss), Germany.

Christoph Clemens (C)

Boehringer Ingelheim Pharma GmbH & Co. KG, Focused Factory Drug Substance, D-88397 Biberach (Riss), Germany.

Liliana Montano Herrera (LM)

Boehringer Ingelheim Pharma GmbH & Co. KG, Bioprocess Development Biologicals, D-88397 Biberach (Riss), Germany.

Sabine Arnold (S)

Boehringer Ingelheim Pharma GmbH & Co. KG, Bioprocess Development Biologicals, D-88397 Biberach (Riss), Germany.

Bettina Knapp (B)

Boehringer Ingelheim Pharma GmbH & Co. KG, Analytical Development Biologicals, D-88397 Biberach (Riss), Germany.

Beate Presser (B)

Boehringer Ingelheim Pharma GmbH & Co. KG, Analytical Development Biologicals, D-88397 Biberach (Riss), Germany.

Alexander Jung (A)

Boehringer Ingelheim Pharma GmbH & Co. KG, Digitalization Development Biologicals CMC, D-88397 Biberach (Riss), Germany.

Thomas Wucherpfennig (T)

Boehringer Ingelheim Pharma GmbH & Co. KG, Bioprocess Development Biologicals, D-88397 Biberach (Riss), Germany.

Erich Bluhmki (E)

Boehringer Ingelheim Pharma GmbH & Co. KG, Analytical Development Biologicals, D-88397 Biberach (Riss), Germany.
University of Applied Sciences Biberach, D-88397 Biberach (Riss), Germany.

Classifications MeSH